0000014272-19-000102.txt : 20190405 0000014272-19-000102.hdr.sgml : 20190405 20190405163238 ACCESSION NUMBER: 0000014272-19-000102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190403 FILED AS OF DATE: 20190405 DATE AS OF CHANGE: 20190405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynch Thomas J. Jr. CENTRAL INDEX KEY: 0001474056 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 19735494 MAIL ADDRESS: STREET 1: 800 HOWARD AVENUE STREET 2: YALE PHYSICIANS BUILDING, 2ND FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 14 FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 14 FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 wf-form4_155449634349912.xml FORM 4 X0306 4 2019-04-03 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001474056 Lynch Thomas J. Jr. BRISTOL-MYERS SQUIBB COMPANY 430 E. 29TH STREET, 14 FLOOR NEW YORK NY 10016 0 1 0 0 EVP & Chief Scientific Officer Common Stock, $0.10 par value 2019-04-03 4 M 0 6296 0 A 23868.964 D Common Stock, $0.10 par value 2019-04-03 4 F 0 3351 46.88 D 20517.964 D Common Stock, $0.10 par value 2019-04-03 4 M 0 5298 0 A 25815.964 D Common Stock, $0.10 par value 2019-04-03 4 J 0 773 0 D 25042.964 D Common Stock, $0.10 par value 2019-04-03 4 F 0 2820 46.88 D 22222.964 D Restricted Stock Units 2019-04-03 4 M 0 6296 0 D 2021-04-03 Common Stock, $0.10 par value 6296.0 12592 D Market Share Units 2019-04-03 4 M 0 5298 0 D 2021-04-03 Common Stock, $0.10 par value 5298.0 12143 D Shares withheld for payment of taxes upon vesting of awards. Represents vesting of one-quarter of market share units granted on April 3, 2017. Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Each restricted stock unit converts into one share of common stock upon vesting. Represents vesting of one-quarter of restricted stock units granted on April 3, 2017. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. /s/ Lisa A. Atkins, attorney-in-fact for Thomas J. Lynch, Jr. M.D. 2019-04-05